compounded glp-1 ban New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Patients struggle as compounded GLP-1

Despite initial concerns over the ability of biguanides to induce lactic acidosis [80], metformin has proven to be a safe and effective member of the therapeutic armamentarium in the management of T2DM

PlexusDx takes precision wellness further by examining how genetic variants in your GLP-1 receptor pathway may influence treatment response, allowing for more personalized therapy planning with your healthcare provider

He has consulted for vTv Therapeutics, XOMA, Sanofi-Aventis, Novartis, and Bayer in the past 5 years

Many hormones such as GCs or insulin can use more than one type of action, which allows for an even more fine-tuned circadian response